title: Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma.
abstract: Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.
authors.affiliation: Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom.
authors.forename: J
authors.initials: J
authors.lastname: Bomanji
authors.forename: J
authors.initials: J
authors.lastname: Glaholm
authors.forename: J L
authors.initials: JL
authors.lastname: Hungerford
authors.forename: S J
authors.initials: SJ
authors.lastname: Mather
authors.forename: M
authors.initials: M
authors.lastname: Granowska
authors.forename: K E
authors.initials: KE
authors.lastname: Britton
authors.forename: R
authors.initials: R
authors.lastname: Whitelocke
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000556:secondary*; D000368:Aged; D000911:Antibodies, Monoclonal; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D010051:Ovarian Neoplasms / Q000473:pathology*; D011877:Radionuclide Imaging
chemical_list: D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes